CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bifrost Biosystems announced today its launch with a vision to power efficient drug discovery through its novel automated Optical Pooled Screening (OPS) platform.
Poster presentation at SITC 2022 highlights high throughput methods for discovery of novel CAR designs with improved persistence BOSTON, Nov. 9, 2022 /PRNewswire/ -- Ginkgo Bioworks (DNA), the leading ...
Figure 1. Optical pooled screens and PerturbView. a) Optical pooled screens (OPS) use targeted in situ sequencing of perturbations to link phenotypes and genotypes from a pooled library, making it ...
New study displays successful implementation of pooled saliva tests for universal screening of congenital cytomegalovirus (cCMV) infection. This approach demonstrates the wide feasibility and benefits ...
Effective cellular therapies for solid tumors remain elusive. Advances in gene editing and synthetic biology offer great potential for improving the safety and functionality of engineered cellular ...
Waypoint Bio has raised $14.5 million in seed funding to support its work pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback